WCITD 2019 Poster Endobarrier NHS Service

UK first National Health Service (NHS) EndoBarrier Service for uncontrolled Diabesity shows the metabolic improvements 6-months after EndoBarrier removal are well maintained.

Authors: REJ Ryder, M Yadagiri, SP Irwin, W Burbridge, T Bashir, MC Wyres, ML Cull, JP Bleasdale, RA Allden, EN Fogden, M Anderson and P Sen Gupta

Discipline

Diabetes
Resource taxonomy
Audit Posters
Clinical taxonomy
Endobarrier Treatments for diabetes Type 2 diabetes mellitus
Listing status
Archived

ABCD Corporate Pharma Sponsors

Gold

  • AstraZeneca UK
  • Boehringer Ingelheim and Lilly Alliance
  • Eli Lilly and Company

Silver

  • A Menarini Farmaceutica Internazionale SRL
  • Sanofi

ABCD Corporate Pump & Device Sponsors

Gold

  • Abbott
  • Dexcom
  • Ypsomed Ltd

Silver

  • A. Menarini Diagnostics
  • Advanced Therapeutics (UK) Ltd
  • Air Liquide Healthcare Ltd
  • Insulet International
  • Medtronic Limited

Bronze

  • Roche Diabetes Care

Contact

Address for correspondence: 
ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602
Email: info@abcd.care

Follow Us

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE  Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE . ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd